Treatment of hypertriglyceridemia and HIV: fenofibrate-induced changes in the expression of chemokine genes in circulating leukocytes.

AIDS Research and Therapy
Carlos Alonso-VillaverdeJorge Joven

Abstract

Fenofibrate changed the expression of chemokine genes in circulating leukocytes of HIV-infected patients with hypertriglyceridemia. The data suggest that fenofibrate when effective in the treatment of lipoprotein abnormalities, may act as a modulator of systemic inflammation. This particular action, therefore, may also influence the clinical course of the disease.

References

Dec 19, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·C HadiganS Grinspoon
Jan 4, 2001·Immunological Reviews·G SimmonsP R Clapham
Mar 29, 2001·AIDS·M DepaironUNKNOWN Swiss HIV Cohort Study
Jun 18, 2004·The American Journal of the Medical Sciences·Archana RaoMario Maldonado
Feb 17, 2007·The Journal of Clinical Investigation·Caroline ChengRob Krams

❮ Previous
Next ❯

Citations

May 11, 2013·AIDS Research and Therapy·Laura Fernández-SenderJorge Joven
Apr 18, 2016·Metabolism: Clinical and Experimental·Amirhossein SahebkarJorge Joven

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR

Software Mentioned

RQ Manager

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.